celllinesdisease

Cancer Cell Lines (all)
1-7HB2	Human mammary luminal epithelial cell line demonstrating branching morphology in co-culture with fibroblasts (subclone of MTSV1-7)
2fTGH IFNg KO Series	Panel of IFNg signalling mutant lines derived from 2fTGH fiborsarcoma cell line, each contains a different mutation in the IFN signalling pathway
CMT 167	Highly metastatic murine alveogenic lung carcinoma tumour line (subclone of CMT 64)
CMT 64	Murine alveogenic lung carcinoma tumour line exhibiting stable growth characteristics and morphology
C-Raf KI D486A	MEF produced from the Raf-1 D486A oncogenic mutant knockin mouse
C-Raf KO	MEF produced from the Raf-1+/- knockout mouse
JIM1	Myeloma cell line with typical plasma cell phenotype (CD38, PCA-1 8A, CD24 positive) deficient in DNA repair (derived from pleural fluid of advanced multiple myeloma patient)
JIM3	Myeloma cell line with typical plasma cell phenotype (CD38, PCA-1 8A, CD24 positive) deficient in DNA repair (derived from pleural fluid of advanced multiple myeloma patient)
MTSV1-7 ce1	Human mammary luminal epithelial cell line MTSV1-7 overexpressing ERBB2
p300-1	Somatic p300 knockout colon carcinoma cell line (derived from HCT116)
PE Ovarian Adenocarcinoma Series	Ovarian adenocarcinoma tumour panel (derived from varying sites and treatment stages)
Raf-1FF/FF	MEF produced from the Raf-1FF/FF knockout mouse

Breast Cancer Cell Lines
1-7HB2	Human mammary luminal epithelial cell line demonstrating branching morphology in co-culture with fibroblasts (subclone of MTSV1-7)
MTSV1-7 ce1	Human mammary luminal epithelial cell line MTSV1-7 overexpressing ERBB2

Colorectal Cancer Cell Lines
p300-1	Somatic p300 knockout colon carcinoma cell line (derived from HCT116)

Lung Cancer Cell Lines
CMT 167	Highly metastatic murine alveogenic lung carcinoma tumour line (subclone of CMT 64)
CMT 64	Murine alveogenic lung carcinoma tumour line exhibiting stable growth characteristics and morphology

Metastasis Cell Lines
CMT 167	Highly metastatic murine alveogenic lung carcinoma tumour line (subclone of CMT 64)
CMT 64	Murine alveogenic lung carcinoma tumour line exhibiting stable growth characteristics and morphology
MTSV1-7 ce1	Human mammary luminal epithelial cell line MTSV1-7 overexpressing ERBB2
TR146	Human Squamous Cell Carcinoma Cell Line

Multiple Myeloma Cell Lines
JIM1	Myeloma cell line with typical plasma cell phenotype (CD38, PCA-1 8A, CD24 positive) deficient in DNA repair (derived from pleural fluid of advanced multiple myeloma patient)
JIM3	Myeloma cell line with typical plasma cell phenotype (CD38, PCA-1 8A, CD24 positive) deficient in DNA repair (derived from pleural fluid of advanced multiple myeloma patient)

Ovarian Adenocarcinoma Cell Lines
PE Ovarian Adenocarcinoma Series	Ovarian adenocarcinoma tumour panel (derived from varying sites and treatment stages)

Immune Response / Disease Cell Lines
CH7C17	T lymphoid cell line expressing stable, functional CD3 and TCR specific to influenza haemagglutinin peptide (HA307-319, in context of HLA-DR1 MHCII molecule)

For further information about cell lines from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Click here to view disclaimer information.